Producing a highly immunogenic synthetic vaccine construct active against HIV-1 subtype C

By Hewer R.   Meyer D.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2680-2683

Elsevier

Access to resources Recommend Favorite

Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein

By Liang X.   Munshi S.   Shendure J.   Mark G.   Davies M.E.   Freed D.C.   Montefiori D.C.   Shiver J.W.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2862-2872

Elsevier

Access to resources Recommend Favorite

Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit

By Barnett S.W.   Rajasekar S.   Legg H.   Doe B.   Fuller D.H.   Haynes J.R.   Walker C.M.   Steimer K.S.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 869-873

Elsevier

Access to resources Recommend Favorite

A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaques

By Kent S.J.   Zhao A.   Dale C.J.   Land S.   Boyle D.B.   Ramshaw I.A.  

Vaccine, Vol. 18, Iss. 21, 2000-04 ,pp. : 2250-2256

Elsevier

Access to resources Recommend Favorite

Potent neutralization of primary HIV-1 isolates by antibodies directed against epitopes present in the V1/V2 domain of HIV-1 gp120

By Pinter A.   Honnen W.J.   Kayman S.C.   Trochev O.   Wu Z.  

Vaccine, Vol. 16, Iss. 19, 1998-11 ,pp. : 1803-1811

Elsevier

Access to resources Recommend Favorite